• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不动杆菌属所致脑膜炎患者治疗过程中出现对美罗培南耐药的情况。

Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter.

作者信息

Núñez M L, Martínez-Toldos M C, Bru M, Simarro E, Segovia M, Ruiz J

机构信息

Laboratory of Microbiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.

出版信息

Scand J Infect Dis. 1998;30(4):421-3. doi: 10.1080/00365549850160774.

DOI:10.1080/00365549850160774
PMID:9817528
Abstract

A case is reported of a patient who developed Acinetobacter meningitis after an external ventricular drainage system had been fitted for control of intracranial pressure. During the process, nine strains of Acinetobacter isolated from her cerebrospinal fluid were indistinguishable by analysis of total genomic DNA by pulse-field gel electrophoresis. The first eight strains were sensitive to meropenem and imipenem (MICs < 1 g/l). The MIC of the last one, which had been recovered after 32 days during two courses of treatment with meropenem, increased to > 32 g/l for meropenem, while with imipenem the increase was minimal (MIC = 1.5 g/l). The microorganism persisted in the central nervous system despite the administration of different antimicrobials, including intraventricular aminoglycosides and six changes in the external ventricular system. The patient died 68 days after admission to the intensive care unit from bilateral cerebral ischemic lesions, intraventricular hemorrhage and cerebral edema with endocraneal hypertension, the Acinetobacter ventriculitis also contributing to this state.

摘要

报道了1例患者,其在安装用于控制颅内压的外部脑室引流系统后发生不动杆菌性脑膜炎。在此过程中,通过脉冲场凝胶电泳分析其脑脊液中分离出的9株不动杆菌的全基因组DNA,结果显示无法区分这些菌株。前8株菌株对美罗培南和亚胺培南敏感(MIC<1μg/ml)。最后1株菌株是在接受两个疗程美罗培南治疗32天后分离得到的,其对美罗培南的MIC增加至>32μg/ml,而对亚胺培南的增加幅度最小(MIC=1.5μg/ml)。尽管使用了包括脑室内氨基糖苷类药物在内的不同抗菌药物,且外部脑室系统更换了6次,但该微生物仍在中枢神经系统持续存在。患者在入住重症监护病房68天后因双侧脑缺血性病变、脑室内出血和伴有颅内高压的脑水肿死亡,不动杆菌性脑室炎也是导致这种情况的原因之一。

相似文献

1
Appearance of resistance to meropenem during the treatment of a patient with meningitis by Acinetobacter.不动杆菌属所致脑膜炎患者治疗过程中出现对美罗培南耐药的情况。
Scand J Infect Dis. 1998;30(4):421-3. doi: 10.1080/00365549850160774.
2
Successful treatment of Acinetobacter meningitis with meropenem and rifampicin.
J Antimicrob Chemother. 2005 Sep;56(3):602-3. doi: 10.1093/jac/dki274. Epub 2005 Jul 26.
3
Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia.美罗培南、舒巴坦和黏菌素不同组合对一株引起脑膜炎和菌血症的多重耐药鲍曼不动杆菌分离株的抗菌作用。
Microb Drug Resist. 2008 Sep;14(3):233-7. doi: 10.1089/mdr.2008.0840.
4
[Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].[美罗培南和亚胺培南对不动杆菌属的耐药突变体选择及抑菌和杀菌活性]
Enferm Infecc Microbiol Clin. 1997 Mar;15(3):140-3.
5
Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.醋酸钙不动杆菌-鲍曼不动杆菌复合体对亚胺培南、美罗培南、舒巴坦和黏菌素的敏感性。
Int J Antimicrob Agents. 2004 May;23(5):487-93. doi: 10.1016/j.ijantimicag.2003.09.026.
6
[Nosocomial meningitis with dual agents and treatment with intraventricular gentamicin].[双重病原体所致医院获得性脑膜炎及脑室内庆大霉素治疗]
Mikrobiyol Bul. 2008 Jul;42(3):497-501.
7
[Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].[亚胺培南和美罗培南对从智利各医院分离出的鲍曼不动杆菌菌株的活性]
Rev Esp Quimioter. 2000 Dec;13(4):405-7.
8
Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.多药耐药鲍曼不动杆菌脑膜炎的成功治疗。
J Infect Dev Ctries. 2007 Dec 1;1(3):342-4.
9
Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections.美罗培南与环丙沙星对从重症监护病房感染中分离出的铜绿假单胞菌和不动杆菌菌株的协同作用研究。
Scand J Infect Dis. 2001;33(11):818-21. doi: 10.1080/00365540110027222.
10
The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000.美罗培南及对照药物对1997 - 2000年从欧洲医院分离出的不动杆菌菌株的活性。
Clin Microbiol Infect. 2003 Jun;9(6):563-7. doi: 10.1046/j.1469-0691.2003.00591.x.

引用本文的文献

1
Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter.微生物耐药动态:对抗菌药物耐药性所构成的全球公共卫生威胁的概述以及最佳应对方法。
Front Public Health. 2020 Nov 4;8:535668. doi: 10.3389/fpubh.2020.535668. eCollection 2020.
2
Successful treatment of multicompartmental cerebral ventriculitis caused by .由……引起的多室性脑室炎的成功治疗 。 (原文不完整,翻译至此)
IDCases. 2017 Nov 21;11:1-2. doi: 10.1016/j.idcr.2017.11.005. eCollection 2018.
3
Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults.
成人脑室内氨基糖苷类药物的疗效、药代动力学及给药方式的系统评价
Neurocrit Care. 2016 Dec;25(3):492-507. doi: 10.1007/s12028-016-0269-3.
4
Evaluation of meropenem regimens suppressing emergence of resistance in Acinetobacter baumannii with human simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model.在体外静脉输注中空纤维感染模型中,用人模拟暴露评估美罗培南方案对鲍曼不动杆菌耐药性产生的抑制作用。
Antimicrob Agents Chemother. 2014 Nov;58(11):6773-81. doi: 10.1128/AAC.03505-14. Epub 2014 Sep 2.
5
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.对碳青霉烯类敏感鲍曼不动杆菌的异质性耐美罗培南。
J Clin Microbiol. 2009 Dec;47(12):4055-9. doi: 10.1128/JCM.00959-09. Epub 2009 Oct 14.
6
Management of meningitis due to antibiotic-resistant Acinetobacter species.耐抗生素不动杆菌属所致脑膜炎的管理
Lancet Infect Dis. 2009 Apr;9(4):245-55. doi: 10.1016/S1473-3099(09)70055-6.
7
Acinetobacter baumannii: emergence of a successful pathogen.鲍曼不动杆菌:一种成功病原体的出现
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
8
Treatment of Bacterial Meningitis.细菌性脑膜炎的治疗
Curr Infect Dis Rep. 2002 Feb;4(1):7-16. doi: 10.1007/s11908-002-0062-7.